BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, May 1, 2026
Home
»
Authors
»
Cormac Sheridan
Articles by Cormac Sheridan
Screentec Signals Discovery Ambitions With Name Change
May 8, 2002
By
Cormac Sheridan
Screentec Signals Discovery Ambitions With Name Change
May 8, 2002
By
Cormac Sheridan
Personal Chemistry Purchases ESyTech To Extend Platform
May 8, 2002
By
Cormac Sheridan
Swiss Firm Axovan Raises CHF30M In Second Round
May 1, 2002
By
Cormac Sheridan
Newron Raises EUR18.5 Million In Second Round For CNS Drugs
May 1, 2002
By
Cormac Sheridan
Glaucus Proteomics Logs On To Dutch Supercomputing Facility
May 1, 2002
By
Cormac Sheridan
NeuroSearch Stops Development Of NS3728 For Sickle-Cell Anemia
May 1, 2002
By
Cormac Sheridan
Newron Raises EUR18.5 Million In Second Round For CNS Drugs
May 1, 2002
By
Cormac Sheridan
Swiss Firm Axovan Raises CHF30M In Second Round
May 1, 2002
By
Cormac Sheridan
Glaucus Proteomics Logs On To Dutch Supercomputing Facility
May 1, 2002
By
Cormac Sheridan
Previous
1
2
…
326
327
328
329
330
331
332
333
334
335
336
Next
